With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.

Moderna’s nearly $20 billion cash hoard has dwindled to a single-digit stash. Following a series of setbacks for the biotech, ...

The new plant will allow the company to execute end-to-end clinical- and commercial-stage production of its mRNA medicines.

Cambridge, USA-based mRNA vaccines company Moderna today announced the expansion of its US manufacturing capabilities with ...

A bipartisan report warned Congress about China’s growing control over the pharmaceutical supply chain. Elsewhere, Alkermes sweetened its bid for Avadel and Moderna is investing $140 million in U.S.

Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network.

Moderna is investing more than $140 million to bring drug manufacturing to its Massachusetts campus, a move that it says will ...

New capabilities strengthen U.S. production, completing Moderna's domestic end-to-end mRNA manufacturing network More than ...

Moderna’s third quarter was shaped by sharply lower demand for COVID-19 vaccines, yet the company delivered results above ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected ...

The second edition of the film festival promoted by TAP Air Portugal on board its aircraft announced its winners yesterday, ...

The second edition of the film festival promoted by TAP Air Portugal on board its aircraft announced its winners on World ...